d-alpha tocopherol has been researched along with natriuretic peptide, brain in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bosch, J; Gerstein, HC; Lonn, E; McQueen, MJ; Yusuf, S | 1 |
| Balion, C; Bickel, C; Blankenberg, S; Cambien, F; Gerstein, H; Lonn, E; McQueen, MJ; Münzel, T; Pogue, J; Rupprecht, HJ; Smieja, M; Tiret, L; Yusuf, S | 1 |
| Cook, NR; Everett, BM; Pradhan, AD; Ridker, PM | 1 |
| Cook, NR; Everett, BM; Pradhan, AD; Ridker, PM; Srivastava, PK | 1 |
4 trial(s) available for d-alpha tocopherol and natriuretic peptide, brain
| Article | Year |
|---|---|
The HOPE (Heart Outcomes Prevention Evaluation) Study and its consequences.
Topics: Angiotensin-Converting Enzyme Inhibitors; Aspirin; Cost-Benefit Analysis; Diabetes Complications; Female; Heart Failure; Humans; Inflammation; Kidney Diseases; Male; Myocardial Infarction; Natriuretic Peptide, Brain; Peptide Fragments; Prospective Studies; Ramipril; Stroke; Ventricular Function, Left; Vitamin E | 2005 |
Comparative impact of multiple biomarkers and N-Terminal pro-brain natriuretic peptide in the context of conventional risk factors for the prediction of recurrent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) Study.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; C-Reactive Protein; Coronary Artery Disease; Female; Fibrinogen; Heart Diseases; Humans; Interleukin-6; Male; Middle Aged; Myocardial Infarction; Natriuretic Peptide, Brain; Predictive Value of Tests; Ramipril; Risk Factors; Vitamin E | 2006 |
Usefulness of B-type Natriuretic Peptides to Predict Cardiovascular Events in Women (from the Women's Health Study).
Topics: Aged; Antioxidants; Aspirin; Cardiovascular Diseases; Case-Control Studies; Cohort Studies; Female; Humans; Incidence; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Platelet Aggregation Inhibitors; Predictive Value of Tests; Risk Factors; Sex Factors; Vitamin E | 2015 |
Impact of Modifiable Risk Factors on B-type Natriuretic Peptide and Cardiac Troponin T Concentrations.
Topics: Aged; Aspirin; Biomarkers; Cardiovascular Diseases; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Incidence; Massachusetts; Middle Aged; Myocardium; Natriuretic Peptide, Brain; Neoplasms; Peptide Fragments; Platelet Aggregation Inhibitors; Prospective Studies; Risk Assessment; Risk Factors; Troponin T; Vitamin E; Vitamins; Women's Health | 2016 |